growth/size/body
|
|
• at ages 1 and 2 years
• normal size spleen at age 3 months
|
hematopoietic system
|
|
• at ages 1 and 2 years
• normal size spleen at age 3 months
|
|
|
• in spleen
|
|
|
• increased spontaneously activated CD69+ cells in spleen
• increased age-associated B cell frequency at age 1 year
|
|
|
• increased frequency at age 1 year
|
|
|
• increased spontaneously activated CD69+ cells in spleen
|
|
|
• in spleen
|
|
|
• total level in serum
• higher levels of anti-RNP-Sm, anti-RNA and ant-DNA IgG in serum at ages, 3 months, 1 year and 1.5+ years
|
|
|
• in serum
|
|
|
• in serum
|
|
|
• in serum
|
immune system
|
|
• normal cell organization and no fibrosis or cell infiltration in spleen
(J:378077)
• normal serum cytokine levels at ages 3 months and 1 year
(J:378077)
|
|
|
• normal spleen
(J:378077)
|
|
|
• at ages 1 and 2 years
• normal size spleen at age 3 months
|
|
|
• in spleen
|
|
|
• increased spontaneously activated CD69+ cells in spleen
• increased age-associated B cell frequency at age 1 year
|
|
|
• increased frequency at age 1 year
|
|
|
• increased spontaneously activated CD69+ cells in spleen
|
|
|
• total level in serum
• higher levels of anti-RNP-Sm, anti-RNA and ant-DNA IgG in serum at ages, 3 months, 1 year and 1.5+ years
|
|
|
• in serum
|
|
|
• in serum
|
|
|
• in serum
|


Analysis Tools